Results 91 to 100 of about 1,058,153 (397)

Pixel classification for automated diabetic foot diagnosis [PDF]

, 2009
Worldwide, more than 180 million people suffer from diabetes mellitus. Approximately 50% of these patients will develop complications to their feet. Neuropathy, combined with poor blood supply and biomechanical changes results in a high risk for foot ...
Baal, J.G. van, Bus, S.A., Hazenberg, S., Heijden, F. van der, Klein, A., Kloeze, C.   +5 more
core   +1 more source

Reduction of gait abnormalities in type 2 diabetic patients due to physical activity: a quantitative evaluation based on statistical gait analysis [PDF]

, 2012
The aim of this study is the objective assessment of gait abnormalities in diabetic patients and the quantification of the benefits of physical activity in improving the gait quality.
Agostini, Valentina, Corgiat Mansin, L., De Luca, R., Knaflitz, Marco   +3 more
core   +1 more source

The effect of foot orthoses on midfoot pain and the volume of bone marrow lesions in the midfoot: a randomized mechanism of action study

Arthritis Care &Research, Accepted Article.
Objective Foot orthoses are thought to improve pain by potentially modifying internal mechanical forces. To test this, we explored whether foot orthoses can modify patterns of bone marrow lesions (BMLs) in people with midfoot pain. Methods Forty‐two people were recruited with midfoot pain and MRI‐confirmed midfoot BMLs.
Jill Halstead, Anne‐Maree Keenan, Philip G. Conaghan, Dennis McGonagle, Anthony C. Redmond   +4 more
wiley   +1 more source

Review and Evaluation of European National Clinical Practice Guidelines for the Treatment and Management of Active Charcot Neuro-Osteoarthropathy in Diabetes Using the AGREE-II Tool Identifies an Absence of Evidence-Based Recommendations

Journal of Diabetes Research
Conclusions: European national CPGs for diabetes provide limited recommendations on active CNO. All guidelines showcased deficits in their methodology, suggesting that more rigorous methods should be employed for diabetes CPG development across Europe.
Nichola Renwick, Jennifer Pallin, Rasmus Bo Jansen, Catherine Gooday, Aroa Tardáguila-Garcia, Irene Sanz-Corbalán, Anastasios Tentolouris, Alexandra Jirkovská, Armin Koller, Anna Korzon-Burakowska, Nina Petrova, Frances Game   +11 more
doaj   +1 more source

Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition)

Burns & Trauma, 2020
In recent years, as living standards have continued to improve, the number of diabetes patients in China, along with the incidence of complications associated with the disease, has been increasing.
A. Wang, Guozhong Lv, Xingbo Cheng, Xianghua Ma, Wei Wang, J. Gui, Ji Hu, Meng Lu, G. Chu, Jin’an Chen, Hao Zhang, Yiqiu Jiang, Yue-Dong Chen, Wengbo Yang, L. Jiang, H. Geng, Ren-dong Zheng, Yihui Li, Wei Feng, Boey Johnson, Wenjuan Wang, Dalong Zhu, Y. Hu   +22 more
semanticscholar   +1 more source

Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes [PDF]

, 2015
reported as vascular complications of diabetes mellitus associated with a high degree of morbidity and mortality. Diabetic foot syndrome (DFS), as defined by the World Health Organization, is an “ulceration of the foot (distally from the ankle and ...
Maida, C, PINTO, Antonio, TUTTOLOMONDO, Antonino   +2 more
core   +1 more source

Adipose Mesenchymal Stem Cell‐Derived Exosomes in Conjunction with Roflumilast Ameliorate Chronic Kidney Disease Through the Modulation of Fibrosis and Inflammation

Advanced Biology, EarlyView.
The novelty of this study showed that the injection of exosomes produced from ADMSCs in combination with Roflumilast poses a more favorable therapeutic outcome for CKD induced by Adriamycin, compared to therapy with exosomes or Roflumilast alone. Roflumilast and exosomes treatment lowered the expression of the apoptotic, fibrotic, and inflammatory ...
Mohamed Ali, Mohamed H. Sherif, Nashwa Barakat, Bassant Yahia, Ahmed A. Shokeir, Basel Sitohy   +5 more
wiley   +1 more source

Bone Substitute in Diabetic Foot Osteomyelitis Treatment

Diabetology
Background: Diabetic foot osteomyelitis (DFO) constitutes a severe and prevalent complication of diabetes mellitus (DM). Individuals afflicted with DM exhibit an elevated risk for DFO development, attributable to a confluence of factors, including ...
Roberto Da Ros, Roberta Assaloni, Andrea Michelli, Barbara Brunato, Enrica Barro, Cesare Miranda   +5 more
doaj   +1 more source

Correlation between type 2 diabetes mellitus and ankle-brachial index in a geographically specific Greek population without peripheral arterial disease

Mìžnarodnij Endokrinologìčnij Žurnal, 2019
Background. Diabetes mellitus (DM) remains one of the fastest growing and most challenging medical diseases today. The Ankle-Brachial Index (ABI) is the ratio of ankle systolic blood pressure divided by brachial systolic pressure.
G. Koufopoulos, K. Pafili, N. Papanas
doaj   +1 more source

Predictors of outcomes in diabetic foot osteomyelitis treated initially with conservative (nonsurgical) medical management: A retrospective study [PDF]

, 2016
The optimal way to manage diabetic foot osteomyelitis remains uncertain, with debate in the literature as to whether it should be managed conservatively (ie, nonsurgically) or surgically. We aimed to identify clinical variables that influence outcomes of
Catherine Gooday, Heiba S, Ian Nunney, Ketan Dhatariya, Paul Zeun, van der Meer JW   +5 more
core   +1 more source